Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Quarterly figures for Sunshine Biopharma Inc., with source filings when available.
67 quarters. Dec 31, 2009 to Jun 30, 2026. USD.
Sunshine Biopharma Inc. has filed its 10-Q within 36 to 50 days of period end across its last 8 quarters. The 10-K runs 80 to 122 days.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 13, 2026 | 44 d | 10-Q | $9.26M | −1.6% | — | |
| Mar 31, 2026 |
| Apr 9, 2026 · after-hours |
| May 13, 2026 |
| 43 d |
| 10-Q |
| $8.09M |
| −9.1% |
| — |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | — | Apr 3, 2026 | 93 d | 10-K | $8.58M | −10.6% | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 13, 2025 | 44 d | 10-Q | $9.42M | +11.6% | — | |
| Q2 2025 | Jun 30, 2025 | — | Aug 12, 2025 | 43 d | 10-Q | $9.41M | +1.2% | -$0.82 | |
| Q1 2025 | Mar 31, 2025 | Apr 2, 2025 · market hours | May 15, 2025 | 45 d | 10-Q | $8.90M | +18.0% | -$0.44 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Apr 1, 2025 | 91 d | 10-K | $9.59M | +24.9% | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 5, 2024 | 36 d | 10-Q | $8.44M | +41.6% | — | |
| Q2 2024 | Jun 30, 2024 | — | Aug 16, 2024 | 47 d | 10-Q | $9.30M | +67.3% | -$43.48 | |
| Q1 2024 | Mar 31, 2024 | Apr 1, 2024 · after-hours | May 20, 2024 | 50 d | 10-Q | $7.54M | +54.1% | -$2.00 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Mar 28, 2024 | 88 d | 10-K | $7.68M | +94.9% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 · market hours | Nov 13, 2023 | 44 d | 10-Q | $5.96M | +4,385.9% | — | |
| Q2 2023 | Jun 30, 2023 | — | Aug 10, 2023 | 41 d | 10-Q | $5.56M | +3,599.7% | — | |
| Q1 2023 | Mar 31, 2023 | — | May 10, 2023 | 40 d | 10-Q | $4.89M | +3,890.4% | -$7.73 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Apr 4, 2023 | 94 d | 10-K | $3.94M | +4,528.7% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 7, 2022 | 38 d | 10-Q | $132.81K | +163.6% | — | |
| Q2 2022 | Jun 30, 2022 | — | Aug 3, 2022 | 34 d | 10-Q | $150.31K | +184.3% | — | |
| Q1 2022 | Mar 31, 2022 | — | May 6, 2022 | 36 d | 10-Q | $122.65K | +206.2% | -$0.23 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 21, 2022 | 80 d | 10-K | $85.12K | +203.9% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 9, 2021 | 40 d | 10-Q | $50.38K | +193.7% | — | |
| Q2 2021 | Jun 30, 2021 | — | Aug 9, 2021 | 40 d | 10-Q | $52.87K | +249.1% | — | |
| Q1 2021 | Mar 31, 2021 | — | May 11, 2021 | 41 d | 10-Q | $40.06K | +260.8% | — | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 30, 2021 | 89 d | 10-K | $28.01K | +165.4% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 12, 2020 | 43 d | 10-Q | $17.15K | +134.1% | — | |
| Q2 2020 | Jun 30, 2020 | — | Aug 19, 2020 | 50 d | 10-Q | $15.15K | +399.3% | — | |
| Q1 2020 | Mar 31, 2020 | — | May 18, 2020 | 48 d | 10-Q | $11.10K | +5,289.3% | — | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | May 1, 2020 | 122 d | 10-K | $10.56K | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 13, 2019 | 44 d | 10-Q | $7.33K | — | — | |
| Q2 2019 | Jun 30, 2019 | — | Aug 15, 2019 | 46 d | 10-Q | $3.03K | — | — | |
| Q1 2019 | Mar 31, 2019 | — | May 20, 2019 | 50 d | 10-Q | $206.00 | −99.8% | — | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Apr 12, 2019 | 102 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 16, 2018 | 47 d | 10-Q | $0.00 | — | — | |
| Q2 2018 | Jun 30, 2018 | — | Aug 17, 2018 | 48 d | 10-Q | $0.00 | — | — | |
| Q1 2018 | Mar 31, 2018 | — | May 22, 2018 | 52 d | 10-Q | $91.17K | — | — | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Apr 2, 2018 | 92 d | 10-K | $0.00 | — | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 15, 2017 | 46 d | 10-Q | $0.00 | — | — | |
| Q2 2017 | Jun 30, 2017 | — | Aug 11, 2017 | 42 d | 10-Q | $0.00 | — | — | |
| Q1 2017 | Mar 31, 2017 | — | May 12, 2017 | 42 d | 10-Q | $0.00 | — | — | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Apr 17, 2017 | 107 d | 10-K | $0.00 | — | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | 45 d | 10-Q | $0.00 | — | — | |
| Q2 2016 | Jun 30, 2016 | — | Aug 16, 2016 | 47 d | 10-Q | $0.00 | −100.0% | — | |
| Q1 2016 | Mar 31, 2016 | — | May 9, 2016 | 39 d | 10-Q | $0.00 | — | — | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Mar 25, 2016 | 85 d | 10-K | $0.00 | — | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 4, 2015 | 35 d | 10-Q | $0.00 | — | — | |
| Q2 2015 | Jun 30, 2015 | — | Aug 6, 2015 | 37 d | 10-Q | $1.71K | — | — | |
| Q1 2015 | Mar 31, 2015 | — | May 7, 2015 | 37 d | 10-Q | $0.00 | — | — | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Mar 11, 2015 | 70 d | 10-K | $0.00 | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 12, 2014 | 43 d | 10-Q | $0.00 | — | — | |
| Q2 2014 | Jun 30, 2014 | — | Aug 12, 2014 | 43 d | 10-Q | $0.00 | — | — | |
| Q1 2014 | Mar 31, 2014 | — | May 9, 2014 | 39 d | 10-Q | $0.00 | — | — | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Mar 19, 2014 | 78 d | 10-K | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 4, 2013 | 35 d | 10-Q | $0.00 | — | — | |
| Q2 2013 | Jun 30, 2013 | — | Aug 6, 2013 | 37 d | 10-Q | $0.00 | — | — | |
| Q1 2013 | Mar 31, 2013 | — | May 9, 2013 | 39 d | 10-Q | — | — | — | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | Mar 15, 2013 | 74 d | 10-K | $0.00 | — | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 8, 2012 | 39 d | 10-Q | $0.00 | — | — | |
| Q2 2012 | Jun 30, 2012 | — | Aug 8, 2012 | 39 d | 10-Q | $0.00 | — | — | |
| Q1 2012 | Mar 31, 2012 | — | May 8, 2012 | 38 d | 10-Q | $0.00 | — | — | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | Mar 19, 2012 | 79 d | 10-K | $0.00 | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 8, 2011 | 39 d | 10-Q | $0.00 | — | — | |
| Q2 2011 | Jun 30, 2011 | — | Aug 9, 2011 | 40 d | 10-Q | $0.00 | — | — | |
| Q1 2011 | Mar 31, 2011 | — | May 12, 2011 | 42 d | 10-Q | $0.00 | — | — | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | Mar 30, 2011 | 89 d | 10-K | $0.00 | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 12, 2010 | 43 d | 10-Q | $0.00 | — | — | |
| Q2 2010 | Jun 30, 2010 | — | Aug 4, 2010 | 35 d | 10-Q | $0.00 | — | — | |
| Q1 2010 | Mar 31, 2010 | — | Apr 30, 2010 | 30 d | 10-Q | $0.00 | — | — | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009 | Dec 31, 2009 | — | — | — | — | — | — | — | |
